- Home
- UNB vs IOBT Comparison
UNB vs IOBT Comparison
Compare UNB & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- IOBT
- Stock Information
- Founded
- UNB 1891
- IOBT 2014
- Country
- UNB United States
- IOBT Denmark
- Employees
- UNB N/A
- IOBT N/A
- Industry
- UNB Major Banks
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- UNB Finance
- IOBT Health Care
- Exchange
- UNB Nasdaq
- IOBT Nasdaq
- Market Cap
- UNB 117.7M
- IOBT 114.6M
- IPO Year
- UNB 1998
- IOBT 2021
- Fundamental
- Price
- UNB $26.07
- IOBT $1.62
- Analyst Decision
- UNB
- IOBT Strong Buy
- Analyst Count
- UNB 0
- IOBT 2
- Target Price
- UNB N/A
- IOBT $8.00
- AVG Volume (30 Days)
- UNB 6.0K
- IOBT 1.1M
- Earning Date
- UNB 10-15-2025
- IOBT 11-11-2025
- Dividend Yield
- UNB 5.56%
- IOBT N/A
- EPS Growth
- UNB N/A
- IOBT N/A
- EPS
- UNB 2.01
- IOBT N/A
- Revenue
- UNB $48,950,000.00
- IOBT N/A
- Revenue This Year
- UNB N/A
- IOBT N/A
- Revenue Next Year
- UNB N/A
- IOBT N/A
- P/E Ratio
- UNB $12.93
- IOBT N/A
- Revenue Growth
- UNB 2.99
- IOBT N/A
- 52 Week Low
- UNB $24.57
- IOBT $0.66
- 52 Week High
- UNB $37.70
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- UNB 47.14
- IOBT 45.53
- Support Level
- UNB $25.83
- IOBT $1.71
- Resistance Level
- UNB $26.34
- IOBT $2.08
- Average True Range (ATR)
- UNB 0.26
- IOBT 0.15
- MACD
- UNB 0.04
- IOBT -0.01
- Stochastic Oscillator
- UNB 53.91
- IOBT 23.45
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.